Business Wire

CQN-CA-BELKIN

25.5.2023 21:47:28 CEST | Business Wire | Press release

Share
CORRECTING and REPLACING Belkin Introduces the Ultimate Power Bank – the BoostCharge™ Fast Wireless Charger for Apple Watch + Power Bank 10K

The sentence just beneath the bullets should read "The BoostCharge Pro Fast Wireless Charger for Apple Watch + Power Bank 10K is now available for $99.99 USD on Belkin.com, and coming soon to select retailers worldwide." (instead of "The BoostCharge Pro Fast Wireless Charger for Apple Watch + Power Bank 10K is now available for $99.99 USD on Belkin.com.")

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230516006027/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Belkin BoostCharge™ Fast Wireless Charger for Apple Watch + Power Bank 10K (Photo: Business Wire)

The updated release reads:

BELKIN INTRODUCES THE ULTIMATE POWER BANK – THE BOOSTCHARGE™ FAST WIRELESS CHARGER FOR APPLE WATCH + POWER BANK 10K

Featuring fast charging for Apple Watch and 20W USB-C PD for charging iPhone anytime, anywhere

Belkin, a leading consumer electronics brand for 40 years, today announces a first-of-its-kind power bank providing fast charge capabilities for newer Apple Watch models1 and iPhone simultaneously, on-the-go. Able to fully charge the Apple Watch Series 8 and Apple Watch Series 7 from 0% to 80% in about 45 minutes, and Apple Watch Ultra 0% to 80% in about an hour,2 the BoostCharge Pro Fast Wireless Charger is the perfect solution for portable power in a pinch.

The powerful new charger was designed in California by Belkin’s award-winning design team and intricately engineered to fit most Apple Watch band sizes and styles. It leverages the latest in technology to charge the Apple Watch Series 8 fourteen times, or iPhone 14 twice3.

Product features:

  • Supports fast charging for Apple Watch Series 8 and Apple Watch Series 7 from 0% to 80% in about 45 minutes, and Apple Watch Ultra 0% to 80% in about an hour2
  • Built with a 20W USB-C PD port for fast charging the power bank itself as well as an additional device
  • Provides up to 36 hours of video playback for iPhone 144 with 10,000mAh cell capacity
  • Built with overcharge protection and fully certified by USB-IF and MFi to deliver safe, fast, efficient power
  • Supports wireless charging for AirPods Pro (2nd generation)
  • Includes 12-inch USB-C cable for charging power bank
  • Ships in plastic-free retail packaging
  • Connected Equipment Warranty covers up to $2500 for peace of mind

The BoostCharge Pro Fast Wireless Charger for Apple Watch + Power Bank 10K is now available for $99.99 USD on Belkin.com, and coming soon to select retailers worldwide.

Media kit is available for download HERE.

About Belkin

Belkin is an accessories market leader delivering power, protection, productivity, connectivity, audio, security, and home automation solutions for a broad range of consumer electronics and enterprise environments. Designed in Southern California and sold in more than 100 countries around the world, Belkin has been a market leader and innovator for 40 years. Its dedication to people-inspired design and quality informs everything from user testing and prototyping process to regulatory compliance, manufacturing and warranty programs. In 2018 Belkin International merged with Foxconn Interconnect Technology to broaden its global influence while maintaining its steadfast focus on R&D, community, education and sustainability.

____________________________
1 Fast charging is only compatible with Apple Watch Series 7, Apple Watch Series 8, and Apple Watch Ultra. Other models will have regular charge times.
2 Testing conducted by Belkin in October 2022; devices tested with latest watchOS 9.0.1 software. Actual results will vary depending on varying factors, including device age, model and usage environment, for individual users.
3 Data based on internal lab testing. Actual results will vary depending on varying factors for individual users.
4 Maximum additional video playback hours calculated by comparing the cell capacity of this power bank with the maximum video playback hours achievable by the iPhone 14 under normal conditions. Actual results will vary depending on varying factors for individual users.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230516006027/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release

Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor

Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release

With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f

Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release

Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th

Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release

Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t

Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye